(Q24246606)

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Comparison of an increased dosage regimen of rabeprazole versus a concomitant dosage regimen of famotidine with rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

Effect of lansoprazole on intragastric pH. Comparison between morning and evening dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

7 January 2021

Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

7 January 2021

Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

7 January 2021

Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

7 January 2021

Helicobacter pylori eradication increases nocturnal acid breakthrough

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

7 January 2021

Helicobacter pylori infection influences nocturnal gastric acid breakthrough

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

7 January 2021

Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

7 January 2021

Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

7 January 2021

Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Pantoprazole-Duodenal Ulcer-Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004275.PUB2

7 January 2021